Shenzhen Creative Industry Co., Ltd.

Shenzhen Creative Industry Co., Ltd. (hereinafter referred to as Creative) was founded in January 2000. It is a national high-tech enterprise integrating the R&D, production, sales and service of medical instruments. In 2018, it joined Lepu (Beijing) Medical Device Co., Ltd. and has now officially merged into the Lepu Medical AI Business Unit. It currently has more than 800 employees, with R&D personnel accounting for more than 30%.
The company's products cover multi-parameter monitors, neurological function reconstruction and pelvic floor rehabilitation treatment systems, home healthcare products, and mobile medical health all-in-one machines. It is one of China's earliest monitor R&D and manufacturing enterprises and one of the earliest enterprises to introduce neurobiofeedback rehabilitation technology into China. Creative has nearly 20 years of accumulated experience in medical device R&D and has become a leading equipment manufacturer in the rehabilitation and monitoring fields, committed to providing high-quality medical products to global customers. Its products are exported to more than 100 countries and regions. All of the company's products have passed NMPA certification for national medical devices, TUV CE certification in the European Union, and FDA approval in the United States.
Lepu (Beijing) Medical Device Co., Ltd. (referred to as Lepu Medical Group) was founded in 1999 and is a joint-stock listed group company (stock code 300003). It is a professional enterprise in China with comprehensive coverage of cardiovascular diagnostic and therapeutic devices, pharmaceuticals, and services. Its revenue in 2018 exceeded 6.9 billion yuan, and in 2019 it was the second-largest listed medical device company in China by market value. It has nearly 8,000 employees worldwide, including nearly 2,000 R&D personnel, and invests nearly 8% of operating revenue in R&D each year. It is the National Engineering Research Center for Cardiovascular Implant Interventional Diagnostic and Therapeutic Devices and Equipment, a National Intellectual Property Advantage Enterprise, and a National High-tech Enterprise.